Charles Farber
About Charles Farber
Charles Farber serves as the Medical Director for Cancer Research Network Development at Atlantic Health System, where he oversees clinical trials and mentors medical professionals. He has extensive experience in hematology and oncology, having previously worked at notable institutions such as Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College.
Work at Atlantic Health System
Charles Farber serves as the Medical Director of Cancer Research Network Development at Atlantic Health System. He has held this position since 2018 in Morristown, New Jersey. In this role, he oversees the administration of clinical trials across a network of six hospitals, ensuring the effective implementation of cancer research initiatives. His responsibilities include coordinating various clinical trials and enhancing the research capabilities of the institution.
Previous Experience at Memorial Sloan Kettering Cancer Center
Prior to his current role, Charles Farber worked at Memorial Sloan Kettering Cancer Center as a Clinical Assistant Professor from 1992 to 1995. During his tenure in New York, he contributed to the education and training of medical professionals in the field of oncology, focusing on the latest advancements in cancer treatment and research.
Education and Expertise
Charles Farber has a robust educational background in the medical field. He earned a Bachelor's degree in Chemistry from the University of Rochester from 1976 to 1980. He then pursued advanced studies at NYU Graduate School of Arts & Sciences, where he achieved a Master's degree in Basic Medical Science from 1980 to 1986. Additionally, he obtained his Doctor of Medicine (MD) degree during this period. His training included a fellowship in Hematology/Oncology at Weill Cornell Medical College from 1988 to 1992, followed by an Internal Medicine residency at the same institution from 1986 to 1988.
Clinical Trials and Research Involvement
Charles Farber is actively involved in conducting phase I, II, and III clinical trials, including both pharmaceutical and cooperative group investigations. His research focuses on blood cancers such as leukemia, lymphoma, and myeloma. He plays a significant role in advancing cancer treatment options through his participation in these clinical trials, contributing to the development of new therapies and improving patient outcomes.
Teaching and Mentoring in Hematology and Oncology
In addition to his clinical and research responsibilities, Charles Farber is dedicated to teaching and mentoring medical students, residents, and fellows in hematology and oncology. His commitment to education ensures that the next generation of medical professionals is well-equipped with the knowledge and skills necessary to excel in the field of cancer treatment and research.